You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 6, June 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Immunolocalization of Activated Transforming Growth Factor {beta}1 in Juvenile Nasopharyngeal Angiofibroma

David G. Dillard, MD; Cynthia Cohen, MD; Susan Muller, DMD, MS; John Del Gaudio, MD; Owen Reichman, MD; Beryl Parrish, MD; David Rackley, BS; Anthony A. Gal, MD

Arch Otolaryngol Head Neck Surg. 2000;126:723-725.

Background  Juvenile nasopharyngeal angiofibroma (JNA) is a histologically benign, locally aggressive neoplasm of the nasopharynx that exclusively affects male adolescents. It is known to be sensitive to androgens, but there are likely intermediary cytokines and/or growth factors that mediate aggressive stromal cell proliferation and angiogenesis. Transforming growth factor {beta}1 (TGF-{beta}1) is a polypeptide that is secreted in an inactive form, cleaved to produce an active form, and then deactivated in the tissues. It activates fibroblast proliferation and is known to induce angiogenesis.

Objectives  To evaluate the presence of activated TGF-{beta}1 within the stroma of JNA specimens and to quantify the percentage of JNA specimens expressing the active growth factor.

Design  Immunohistochemical analysis was performed on 19 specimens of JNA using a unique antibody that identifies only the activated form of TGF-{beta}1. The percentage of cells staining positively for activated TGF-{beta}1 was determined semiquantitatively by visual methods.

Results  Of 19 cases stained, all 19 (100%) showed strong positive staining (2 cases with 33%-66% of cells staining and 17 with 66%-100% of cells staining). Activated TGF-{beta}1 was identified in stromal cell nuclei and cytoplasm and in the endothelium of the capillaries within all specimens of JNA.

Conclusions  The localization of activated TGF-{beta}1 to the fibroblasts and endothelial cells within JNA tumors suggests that TGF-{beta}1 may play a role in the stromal cell proliferation and angiogenesis associated with JNA. Additional receptor studies and more quantitative methods of analysis are needed to further define the role of TGF-{beta}1 in the pathogenesis of JNA.


From the Departments of Otolaryngology–Head and Neck Surgery (Drs Dillard, Muller, DelGaudio, Reichman, and Parrish and Mr Rackley) and Pathology and Laboratory Medicine (Drs Cohen, Muller, and Gal), Emory University School of Medicine, Atlanta, Ga.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vessel Density, Proliferation, and Immunolocalization of Vascular Endothelial Growth Factor in Juvenile Nasopharyngeal Angiofibromas
Brieger et al.
Arch Otolaryngol Head Neck Surg 2004;130:727-731.
ABSTRACT | FULL TEXT  

Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-{beta}1
Corallini et al.
Carcinogenesis 2003;24:1435-1444.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.